Knowledge and Uptake of Covid-19 Vaccine Amongst Students of Tertiary Institutions in Oghara, Delta State, Nigeria
DOI:
https://doi.org/10.4314/Keywords:
Acceptability, COVID-19 vaccine, Knowledge, UptakeAbstract
Introduction: Coronavirus disease is a global health emergency that began in China, in 2019. It resulted in several morbidity and mortality worldwide. The introduction of Covid-19 vaccine in Nigeria was hampered by wide spread vaccine hesitancy due to factors like misinformation, rapid rollout, safety concerns, potential adverse effects, and conspiracy theories. The objective of this study was to assess the knowledge and uptake of Covid-19 vaccine among students of tertiary institutions in Oghara, Delta State, Nigeria.
Materials and methods: A descriptive cross-sectional study design was employed to collect data from 354 participants in three tertiary institutions in Oghara using multistage sampling technique. Data analysis was done using IBM-SPSS version-26 software. Both descriptive and inferential statistics were done and level of significance set at P<0.05.
Results:Most respondents were between ages 21-25 (53.2%) with females constituting 55.6%. Seventyone percent of respondents had good knowledge of Covid-19 vaccine. Only 27% had been vaccinated while 73% are unvaccinated. Among those unvaccinated, 57.7% were not willing to be vaccinated. Good knowledge of Covid-19 vaccine (P=0.048) and having previous exposure to information, education and communication about Covid-19 vaccine (P=0.024) were found to have a statistically significant association with the uptake of Covid-19 vaccine.
Conclusion: Majority of students of tertiary institutions in Oghara have good knowledge of COVID-19 vaccine however the uptake was poor. More effort should be invested in providing accurate information about the vaccines while mitigating misinformation.
References
Orok E, Ndem E, Daniel E. Knowledge, attitude and perception of medical students on COVID-19 vaccines: a study carried out in a Nigerian university. Front Public Health. 2022;10:942283. doi:10.3389/fpubh.2022.942283.
WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 [Internet]. 2024. Available from:
O'Driscoll M, Ribeiro Dos Santos G, Wang L, Cummings D, Azman AS, Paireau J. Agespecific mortality and immunity patterns of S A RS-CoV-2. NAture. 2 0 2 1 ; 5 9 0 (7844):140–145. doi:10.1038/s41586-020- 2918-0.
Güner R, Hasanoğlu I, Aktaş F. COVID-19: prevention and control measures in community. Turk J Med Sci. 2020;50(9SI1):571-577. doi:10.3906/sag-2004-146.
COVID-19 cases | WHO COVID-19 dashboard [Internet]. Datadot. Available from: https://data.who.int/dashboards/
covid19/cases?n=c
Nigeria Centre for Disease Control. First case of Coronavirus disease confirmed in N i g e r i a . 2 0 2 0 . Av a i l a b l e f r o m : https://ncdc.gov.ng/news/227/first-caseof-corona-virus-disease-confirmed-innigeria.
Nigeria Centre for Disease Control. NCDC Coronavirus COVID-19 microsite. 2022 Available from: www.covid19.ncdc.gov.ng |
www.ncdc.gov.ng
World Health Organization. Impact of COVID-19 on people's livelihoods, their health and our food systems [Internet]. 2020. [cited 2021 Feb 2]. Available from: https://www.who.int/news/item/13-10-2020-impact-of-covid-19-on-peopleslivelihoods-their-health-and-our-foodsystems.
Liu C, Zhou Q. Research and development on therapeutic agents and vaccines for COVID19 and related human coronavirus disease. A C S C e n t S c i . 2 0 2 0 ; 6 : 3 1 5 – 3 1 .doi:10.1021/acscentsci.0c00272.
Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol. 2021;71: 111–116. Available from: https://doi.org/10.1016/j.coi.2021.07.003.
World Health Organization. WHO lists additional COVID-19 vaccine for emergencyu s e a n d i s s u e s i n t e r i m p o l i c y recommendations. 2021. [cited 2021 June 22]. Available from: https://www.who.int/news/item/07-05-2021-who-lists-additionalcovid-19-vaccine-for-emergency-use-andissues-interim-policy-recommendations.
Excler JL, Saville M, Privor-Dumm L, Gilbert S, Hotez PJ, Thompson D, et al. Factors, enablers and challenges for COVID-19 vaccine development. BMJ Global Health. 2023;8(6): e011879. Ava il abl e from: https://www.ncbi.nlm.nih.gov/pmc/articles /PMC10255030/.
Li YD, Chi WY, Su JH. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020;27:104. doi:10.1186/s12929-020-00695-2.
Abu Hammour K, Abu Farha R, Manaseer Q, Al-Manaseer B. Factors affecting the public's knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated. J Am Pharm Assoc. 2022;62(1):309–316. Available from: https://doi.org/10.1016/j.japh.2021.06.021.
World Health Organization. Ten threats to global health in 2019. 2019. Available from: https://www.who.int/news-room/ spotlight/ten-threats-to-global-health-in2019.
Freeman D, Loe BS, Chadwick A, Vaccari C, Waite F, Rosebrock L, et al. COVID-19 vaccine hesitancy in the UK: the Oxford Coronavirus Explanations, Attitudes, and Narratives Survey (OCEANS) II. Psychol Med. 2020;52(14):3127–3141. doi:10.1017 /s0033291720005188.
Tavolacci MP, Dechelotte P, Ladner J. COVID-19 vaccine acceptance, hesitancy, and resistance among university students in Fr a n c e . Va c c i n e s . 2 0 2 1 ; 9 ( 6 ) : 6 5 4 .doi:10.3390/vaccines9060654.
Federal Republic of Nigeria. Legal Notice of Publication of 2006 Census Final Results. Extraordinary Federal Republic of Nigeria Official Gazette. 2009; 96 (2):B26. The Federal G o v e r n m e n t P r i n t e r , A b u j a , Nigeria.FGP16/22009/10,000 (OL 02). .
Available from: https://archive.gazettes.africa/archive/ng/2009/ng-governmentgazette-dated-2009-02-02-no-2.pdf
Igben JL, Eregare EF. Predictive analysis of future rainforest covers depletion in Oghara, D e l t a st a t e , N i g e ri a . D i s cove r y.
;58(314):89-96.
Araoye OM. Research methodology with statistics for health and social sciences. 2nd ed. Ilorin: Nathadex; 2004. p. 118.
Akinsunmade OM, Ogunyemi AO, Isikekpei BC, Maduafokwa BA, Otokpa E, Okerinde SS. Perceptions and uptake of COVID-19 vaccines amongst undergraduate students in a tertiary institution in Lagos State. Niger Postgr a d Me d J. 2023;30(2):104-109. doi:10.4103/npmj.npmj_332_22.
Isiguzo GC, Stefanovics E, Unamba NN, Mbam TT, Anyaehie UG, Chukwu CC, et al. Perceptions of the COVID-19 vaccine and
willingness to receive vaccination among health workers in Nigeria: a cross-sectional study. Niger J Clin Pract. 2024;27(1):102-108.
doi:10.4103/njcp.njcp_537_23.
Tobin EA, Okonofua M, Adeke A, Obi A. Willingness to accept a COVID-19 vaccine in Nigeria: a population-based cross-sectional study. Niger J Clin Pract. 2021;7(2):53–60.
Akan H, Gurol Y, Izbirak G, Ozdatl S, Yilmaz G, Vitrinel A. Knowledge and attitudes of university students toward pandemic influenza: a cross-sectional study from Turkey. BMC Public Health. 2010;10:413. doi:10.1186/1471-2458-10-413. [23]
Abu Hammour K, Abu Farha R, Manaseer Q, Al-Manaseer B. Factors affecting the public's knowledge about COVID-19 vaccines and the influence of knowledge on their decision to get vaccinated. J Am Pharm Assoc. 2022;62(1):309–316. Available from: https://doi.org/10.1016/j.japh.2021.06.021.
Effiong FB, Hassan IA, Olawuyi DA, Ogbonna CP, Araoye JB, Bassey EE, et al. Awareness, coverage, and barriers to COVID19 vaccination among undergraduate students in Nigeria. Int J Med Students. 2 0 2 3 ; 1 1 ( 4 ): 2 6 2 – 2 7 0 . d o i : 1 0 . 5 1 9 5 / ijms.2023.1908.
Jain J, Suman S, Akhil G, Manoj G, Pankaj B, Pankaja R. COVID-19 vaccine hesitancy among undergraduate medical students: results from a nationwide survey in India. E p i d e m iol I n f e c t . 2 0 2 1 ; 1 4 9 : e 1 3 2 . doi:10.1017/S0950268821001205. [26]
Adetayo AJ, Sanni BA, Aborisade MO. COVID-19 vaccine knowledge, attitude, and acceptance among students in selected universities in Nigeria. Dr Sulaiman Al Habib Med J. 2021;3(4):162. Available @ h tt p s: / /www. a tl a n tis- p r e ss. c om/ journals/dsahmj/125961617.
Bacon AM, Taylor S. Vaccination hesitancy and conspiracy beliefs in the UK during the SARS-CoV-2 (COVID-19) pandemic. Int J
B e h a v M e d . 2 0 2 1 ; 2 : 0 1 2 3 4 5 6 7 8 9 . doi:10.1007/s12529-021-10029-7.
Sherman SM, Smith LE, Sim J, Amlôt R, Cutts M, Dasch H, et al. COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional sur vey. Hum Vaccin Immu n ot h er. 2 0 2 1 ; 1 7 ( 6 ): 1 6 1 2–1 6 2 1 . doi:10.1080/216455 15.2020.1846397.
Shahwan M, Suliman A, Abdulrahman Jairoun A, Alkhoujah S, Al-hemyari SS, AlTamimi SK, et al. Prevalence, knowledge and potential determinants of COVID-19 vaccine acceptability among university students in the United Arab Emirates: findings and impl i c a tions. J Mu lti d isci p He a lt h c.2022;15:81–92.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 African Journal of Tropical Medicine and Biomedical Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Key Terms:
- Attribution: You must give appropriate credit to the original creator.
- NonCommercial: You may not use the material for commercial purposes.
- No Derivatives: You may not remix, transform, or build upon the material.
- Sharing: You may distribute the original work, but only for non-commercial purposes and without modifications.
For full details, please review the Complete License Terms.
How to Cite
